BioStem Technologies, Inc. (BSEM) vs Filana Therapeutics, Inc. (FLNA)
A side-by-side comparison of BioStem Technologies, Inc. and Filana Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BSEM
BioStem Technologies, Inc.
$2.47HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
FLNA
Filana Therapeutics, Inc.
$0.87HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BSEM vs FLNA
growth of $100 · dividends reinvested · last 1yBSEM -56.1% (-56.1%/yr)FLNA -57.6% (-57.6%/yr)BSEM compounded faster over this window
BSEM FLNA
BSEM vs FLNA: by the numbers
- •FLNA is the larger company ($42M vs $42M market cap).
- •Both run net losses; FLNA's is the smaller (0.00% vs -13.86% net margin).
Metrics side by side
Valuation
| Metric | BSEM | FLNA |
|---|---|---|
| P/B ratio | 1.52 | 0.66 |
Profitability
| Metric | BSEM | FLNA |
|---|---|---|
| Gross margin | 93.13% | 0.00% |
| Operating margin | -1.45% | 0.00% |
| Net margin | -13.86% | 0.00% |
| ROE | -102.45% | -66.47% |
| ROIC | -80.92% | -72.12% |
Growth (annualized)
| Metric | BSEM | FLNA |
|---|---|---|
| Total return CAGR (5Y) | 15.72% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.